Page 50 - P4403.14-V105 June OTC Magazine Main Mag (Print Ready)

50 FEMININE HEALTH

Why is Women’s Intimate Health Important?

• The category is worth £103m (Source: Circana, IRI All Outlets inc Chemists, 52 w/e 1st March 2025) & is set to see
strong growth over the next 5 years
• 75% of women experience Thrush over their lifetime
(Global burden of recurrent vulvovaginal candidiasis: a systematic review. Denning et al. Lancet 2018. Women’s Intimate Health Usage & Attitudes
Study, GFK, 2014)
• 50-60% of adult women will have at least one UTI in their life
(Source: Medina M, et al. Ther Adv Urol. 2019;11:175628721983217)
1.6% Brand Value Share
1.6%
1.5% 7.9%
1.5%
7.9%
Canesten
1.7% Canesten
1.7%
2.9% Balance Activ
Balance Activ
2.9%
2.9% Vagisan
2.9%
Vagisan
3.4% Femfresh
Femfresh
3.4%
Care +
46.4% Care +
7.2% 46.4% Replens Md
Replens Md
7.2%
Private Label
Private Label
10.2% Cystopurin
Cystopurin
10.2%
Other
Other
14.3% Vagisil
Vagisil
14.3%
Bells
Bells
Source: Circana, IRI All Outlets inc Chemists, 52 w/e 1st March 2025
Women’s Health is segmented into 8 key sub-categories,
with Thrush accounting for half of the category:

5.8% 2.9% 1.5% Value Share of Women’s
Intimate Health
5.9%
Thrush Treatment
1.6% Cystitis Treatment
1.5% 7.9% Wellness/Prevention
8.4%
Feminine Hygiene
Canesten
1.7% 51.5%
Balance Activ
2.9% 9.4% Bv Treatment
2.9% Self Test Kit
Vagisan
Femfresh
3.4% Vaginal Dryness
14.6% Itch Relief
Care +
46.4%
7.2% Replens Md
Private Label
Source: Circana, Chemists inc BT SD WL, 52 w/e 1st March 2025
10.2% Cystopurin
Other
Vagisil
14.3%
Bells

12/05/2025 16:39:50
P4403.14-V105 June OTC Magazine 2025 ANT 12.5.2025.indd 50 12/05/2025 16:39:50
P4403.14-V105 June OTC Magazine 2025 ANT 12.5.2025.indd 50